Healthcare provider profile · identity verified

Brandon Daniel Steger, MD

Family Practice · TULSA, OK · NPI 1558620799

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	885	185
Levothyroxine Sodium	Levothyroxine Sodium	687	140
Atorvastatin Calcium	Atorvastatin Calcium	685	156
Omeprazole	Omeprazole	590	137
Losartan Potassium	Losartan Potassium	535	112
Potassium Chloride	Potassium Chloride	477	97
Warfarin Sodium	Warfarin Sodium	377	33
Pravastatin Sodium	Pravastatin Sodium	370	103
Lisinopril	Lisinopril	335	84
Tamsulosin Hcl	Tamsulosin Hcl	332	81
Metoprolol Succinate	Metoprolol Succinate	323	77
Eliquis	Apixaban	312	50
Sertraline Hcl	Sertraline Hcl	288	55
Hydrochlorothiazide	Hydrochlorothiazide	280	62
Furosemide	Furosemide	270	57
Rosuvastatin Calcium	Rosuvastatin Calcium	269	61
Metformin Hcl	Metformin Hcl	257	61
Metoprolol Tartrate	Metoprolol Tartrate	235	58
Simvastatin	Simvastatin	232	68
Spironolactone	Spironolactone	220	39
Carvedilol	Carvedilol	216	40
Gabapentin	Gabapentin	194	45
Ozempic	Semaglutide	191	24
Donepezil Hcl	Donepezil Hcl	182	28
Metformin Hcl Er	Metformin Hcl	170	36
Allopurinol	Allopurinol	156	32
Clopidogrel	Clopidogrel Bisulfate	149	28
Mirtazapine	Mirtazapine	137	30
Finasteride	Finasteride	133	34
Pantoprazole Sodium	Pantoprazole Sodium	125	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	125	21
Doxazosin Mesylate	Doxazosin Mesylate	123	21
Alendronate Sodium	Alendronate Sodium	122	27
Citalopram Hbr	Citalopram Hydrobromide	106	24
Duloxetine Hcl	Duloxetine Hcl	105	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	101	23
Memantine Hcl	Memantine Hcl	96	16
Albuterol Sulfate Hfa	Albuterol Sulfate	91	37
Bumetanide	Bumetanide	89	16
Atenolol	Atenolol	88	20
Escitalopram Oxalate	Escitalopram Oxalate	87	16
Montelukast Sodium	Montelukast Sodium	86	20
Fluticasone Propionate	Fluticasone Propionate	84	21
Myrbetriq	Mirabegron	84	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	78	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	77	66
Novolog Flexpen	Insulin Aspart	76	15
Pregabalin	Pregabalin	76	17
Torsemide	Torsemide	75	19
Glipizide	Glipizide	71	17
Trulicity	Dulaglutide	70	11
Ropinirole Hcl	Ropinirole Hcl	66	11
Sucralfate	Sucralfate	66	25
Trazodone Hcl	Trazodone Hcl	66	15
Valsartan	Valsartan	66	17
Jardiance	Empagliflozin	60	13
Amiodarone Hcl	Amiodarone Hcl	58	13
Jantoven	Warfarin Sodium	58	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	16
Xarelto	Rivaroxaban	55	11
Prednisone	Prednisone	54	42
Doxycycline Hyclate	Doxycycline Hyclate	51	39
Arexvy	Rsvpref3 Antigen/As01e/Pf	49	49
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	14
Shingrix	Varicella-Zoster Ge/As01b/Pf	49	38
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Clonazepam	Clonazepam	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	11
Famotidine	Famotidine	43	13
Triamcinolone Acetonide	Triamcinolone Acetonide	43	25
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	41	41
Lansoprazole	Lansoprazole	41	11
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Glipizide Er	Glipizide	38	suppressed
Ondansetron Odt	Ondansetron	38	12
Buspirone Hcl	Buspirone Hcl	37	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	37	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	36	36
Cephalexin	Cephalexin	36	25
Ipratropium Bromide	Ipratropium Bromide	36	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	16
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	33	suppressed
Diltiazem Hcl	Diltiazem Hcl	33	suppressed
Olanzapine	Olanzapine	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	21
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	18
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Latanoprost	Latanoprost	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Meloxicam	Meloxicam	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Cefdinir	Cefdinir	25	19
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Methylprednisolone	Methylprednisolone	24	21
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	11
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Albuterol Sulfate	Albuterol Sulfate	20	suppressed
Azithromycin	Azithromycin	20	18
Lorazepam	Lorazepam	20	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Creon	Lipase/Protease/Amylase	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Cholestyramine Light	Cholestyramine	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Levofloxacin	Levofloxacin	18	15
Propranolol Hcl	Propranolol Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Digoxin	Digoxin	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Amoxicillin	Amoxicillin	15	13
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Risperidone	Risperidone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error